AIM - AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series | Benzinga
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company"), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series on Wednesday, June 5, 2024 at 12:00 PM ET.
As part of the event, Mr. Equels will provide a corporate overview and business outlook. In ...